PT Nanotech Indonesia Global Tbk (IDX:NANO)
Indonesia · Delayed Price · Currency is IDR 33.00
-1.00 (-2.94%)
Sep 2, 2026, 1:38 PM WIB
IDX:NANO Revenue
PT Nanotech Indonesia Global Tbk had revenue of 218.15B IDR in the half year ending June 30, 2026, with 344.64% growth. This brings the company's revenue in the last twelve months to 237.83B, up 101.05% year-over-year. In the year 2025, PT Nanotech Indonesia Global Tbk had annual revenue of 72.17B, down -37.17%.
Revenue (ttm)
237.83B
Revenue Growth
+101.05%
P/S Ratio
0.61
Revenue / Employee
12.52B
Employees
19
Market Cap
145.70B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 72.17B | -42.70B | -37.17% |
| Dec 31, 2024 | 114.86B | 31.04B | 37.03% |
| Dec 31, 2023 | 83.82B | 39.12B | 87.50% |
| Dec 31, 2022 | 44.70B | 17.93B | 66.97% |
| Dec 31, 2021 | 26.77B | 10.73B | 66.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PT Kalbe Farma Tbk. | 37.72T |
| PT Siloam International Hospitals Tbk | 13.51T |
| PT Mitra Keluarga Karyasehat Tbk | 5.57T |
| PT Millennium Pharmacon International Tbk | 4.30T |
| PT Sejahteraraya Anugrahjaya Tbk | 2.70T |
| PT Phapros Tbk | 965.50B |
| PT Ikapharmindo Putramas Tbk | 400.25B |
| PT Cipta Sarana Medika Tbk | 136.01B |